Living and Aging with HIV: Policies that Impact Women & Girls (March 2017)
The 30 for 30 Campaign, CHANGE, Advocates for Youth, HIVEonline, and OWEL convened a webinar examining how woman and girls across the age spectrum are affected by HIV. The webinar focused on: younger women, the Affordable Care Act, and sex education; women of reproductive age and fertility desires; and women living with HIV who are aging. Click here to view a recording of the webinar.
Health Beyond Borders: A Look at Immigrant Women on World AIDS Day (December 2016)
The 30 for 30 Campaign, joined by the African Services Committee, National Latina Institute for Reproductive Health, and the San Francisco AIDS Foundation, discussed the unique needs of immigrant women impacted by HIV and commemorated the 2016 World AIDS Day. Click here to view a recording of the webinar.
Ending Personal/Structural Violence and Addressing the Impact of Trauma on Women Living with HIV (August 2016)
The 30 for 30 Campaign held a webinar with Christie’s Place, the Positive Women’s Network, Futures Without Voices, Lambda Legal, and HIPS to discuss the impact of violence against women and trauma on women living with HIV and how to advocate for policy solutions to meet their unique needs. The speakers also spoke about the intersections of criminalization of sex work and HIV its effect on public health and reproductive justice. Click here to view a recording of the webinar.
Meeting All of Our Needs: Integrating Reproductive Justice & HIV for Women and Girls in the U.S. and Globally (November 2015)
The 30 for 30 Campaign and CHANGE hosted a webinar discussing how advocates, activists, researchers, and providers can bridge silos, connect cross regions, and build the movement to ensure access to integrated sexual and reproductive health, rights, and justice for all. Click here to view a recording of the webinar.
PrEP at Two Years–and Still Counting Women in (June 2014)
The US Women & PrEP Working Group, SisterLove and AVAC hosted a webinar marking the two-year anniversary of the FDA licensing of Truvada as PrEP in the US. This webinar provided an opportunity to share updates and resources in the field and to discuss how far we’ve moved in getting women involved in the rollout of PrEP. It also reviewed what we know and don’t know about women’s motivations and barriers to consider daily oral PrEP as an intervention.